SCHEMBL252297

SCHEMBL252297

C=CC(OC(C=C)c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.37
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 3/20 0.36
TSHR P16473 2/20 0.36
DPP4 P27487 2/20 0.36
F2 P00734 1/20 0.36
HPGD P15428 3/20 0.35
USP2 O75604 2/20 0.35
TP53 P04637 2/20 0.35
HSD17B10 Q99714 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 2/20 0.35
ALOX12 P18054 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroquinone SCHEMBL4865344 0.89 IDO1 (0.44) CYP2C19ALDH1A1HSD17B10TDP1LMNA
SCHEMBL8418591 0.87 ALDH1A1 (0.36) CYP3A4CYP2C19KDM4EMAPTALDH1A1
SCHEMBL15209920 0.87 ALDH1A1 (0.36) CYP3A4KDM4EMAPTALDH1A1ALOX15
SCHEMBL3802806 0.85 CYP2C19 (0.36) CYP3A4CYP2C19KDM4EMAPTALDH1A1
SCHEMBL2488648 0.85 CYP2C19 (0.36) CYP3A4CYP2C19KDM4EMAPTALDH1A1
SCHEMBL8419728 0.85 KDM4E (0.37) CYP3A4CYP2C19KDM4EMAPTALDH1A1
SCHEMBL7156401 0.85 CYP3A4 (0.33) CYP3A4CYP2C19KDM4EMAPTALDH1A1
Glycerin SCHEMBL6931931 0.84 CASR (0.38) CYP2C19KDM4EALDH1A1TSHRLMNA
SCHEMBL3298577 0.83 ALDH1A1 (0.34) CYP3A4KDM4EMAPTALDH1A1ALOX15
SCHEMBL3296386 0.83 TAAR1 (0.34) CYP3A4KDM4EMAPTALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117047-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM ELITE ELECTRONIC MAT ZHONGSHAN CO LTD (CN) 2026-04-30 US claimed
EP-3636692-B1 POLY(ARYLENE ETHER) COPOLYMER SHPP GLOBAL TECH BV (NL) 2026-04-29 EP claimed
US-20260109852-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM ELITE ELECTRONIC MATERIAL (KUNSHAN) CO., LTD. (CN) 2026-04-23 US claimed
US-12606655-B2 Curable resin, curable resin composition, and cured product DIC CORPORATION (JP) 2026-04-21 US claimed
US-20260062507-A1 PHOSPHORUS-CONTAINING POLYMER, RESIN COMPOSITION AND ARTICLE MADE THEREFROM ELITE ELECTRONIC MAT KUNSHAN CO LTD (CN) 2026-03-05 US claimed
US-20260049097-A1 LOW DIELECTRIC COMPOUND, MANUFACTURING METHOD THEREOF, RESIN COMPOSITION, AND ARTICLE MADE THEREFROM ELITE ELECTRONIC MATERIAL (ZHONGSHAN) CO., LTD. (CN) 2026-02-19 US claimed
US-20250361381-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM ELITE ELECTRONIC MAT ZHONGSHAN CO LTD (CN) 2025-11-27 US claimed
US-20250354011-A1 FLAME RETARDED RESIN COMPOSITION AND ARTICLES MADE THEREFROM ICL IP AMERICA INC (US) 2025-11-20 US claimed
US-12378402-B2 Resin composition and article made therefrom ELITE ELECTRONIC MATERIAL (KUNSHAN) CO., LTD. (CN) 2025-08-05 US claimed
EP-3885392-B1 FUNCTIONALIZED POLY(ARYLENE ETHER) COPOLYMER, METHOD OF MAKING AND ARTICLES OBTAINED THEREFROM SHPP GLOBAL TECH BV (NL) 2025-07-02 EP claimed
US-4774316-A Copolymer of vinylbenzyl ether of polyhydric halogenated phenolic compound and aromatic polycyanate ester compound THE DOW CHEMICAL COMPANY (US) 1988-09-27 US claimed
EP-0260443-A2 New monomers and oligomers containing a plurality of vinylbenzyl ether groups, method for their preparation and cured products therefrom THE DOW CHEMICAL COMPANY (US) 1988-03-23 EP claimed
EP-0258695-A1 Polyfunctional vinylbenzyl ethers of polyhydric halogenated phenolic compoundsand copolymer compositions containing them THE DOW CHEMICAL COMPANY (US) 1988-03-09 EP claimed
WO-1988001262-A1 VINYLBENZYL ETHERS OF POLYHYDRIC HALOGENATED PHENOLIC COMPOUNDS THE DOW CHEMICAL COMPANY (US) 1988-02-25 WO claimed
US-4707558-A USING A POLAR APPOTIC SOLVENT TO REACT AN ALKALI METAL PHENOXIDE BASED ON A POLYHYDROXY COMPOUND WITH A VINYLBENZYL HALIDE THE DOW CHEMICAL COMPANY (US) 1987-11-17 US claimed
US-4533766-A Process for the production of dihydroxybenzenes DEGUSSA AKTIENGESELLSCHAFT (DE) 1985-08-06 US claimed
US-4483984-A Phenoxiodinin-5-ium antimicrobial compounds THE DOW CHEMICAL COMPANY (US) 1984-11-20 US claimed
US-4440943-A BACTERICIDES; FUNGICIDES; ANTICARIES AGENTS; ORAL DISEASES THE DOW CHEMICAL COMPANY (US) 1984-04-03 US claimed
US-4418203-A PHENYL ALLYL ETHERS, CATALYSIS, FLUORINATED ALCOHOL SOLVENTS SHELL OIL COMPANY (US) 1983-11-29 US claimed
US-4242408-A Easily disposable non-woven products having high wet strength at acid pH and low wet strength at base pH THE DOW CHEMICAL COMPANY (US) 1980-12-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062507-A1 PHOSPHORUS-CONTAINING POLYMER, RESIN COMPOSITION AND ARTICLE MADE THEREFROM LCP1, PBRM1, PCNA CYP3A4 3448/4885CYP2C19 3084/4885KDM4E 2692/4885
US-12606655-B2 Curable resin, curable resin composition, and cured product ARCN1, CAPZA1, CAPZB CYP3A4 3762/4885CYP2C19 1714/4885KDM4E 657/4885
US-20260049097-A1 LOW DIELECTRIC COMPOUND, MANUFACTURING METHOD THEREOF, RESIN COMPOSITION, AND ARTICLE MADE THEREFROM GJB2, GJA1, CDH1 CYP3A4 1518/4885CYP2C19 1967/4885KDM4E 1616/4885
US-20260109852-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM MACF1, SMCHD1, SMC2 CYP3A4 1961/4885CYP2C19 2768/4885KDM4E 1334/4885
US-20260117047-A1 RESIN COMPOSITION AND ARTICLE MADE THEREFROM ITGAM, CDC73, ITGB8 CYP3A4 1993/4885CYP2C19 2399/4885KDM4E 2284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.